Bruton's tyrosine kinase (BTK) inhibitors: an updated patent review (2019-2024).

已完结 10 由 Luke 发布于 2026/1/30 16:20:14

DOI:10.1080/13543776.2025.2554638
作者：Ze-Xi Cui,?Sheng-Xin Yao,?Yue-Xi Zhang,?Hai-Yue Lu,?Li-Ping Sun,?Lei Shi
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Introduction: Bruton's tyrosine kinase (BTK) is a critical regulator in the pathogenesis of B-cell malignancies, inflammatory diseases, and autoimmune diseases. In recent years, BTK inhibito

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Conditional requirement for dimerization of the membrane-binding module for BTK signaling in lymphocyte cell lines